CBAY Insider Trading

Insider Ownership Percentage: 5.60%
Insider Buying (Last 12 Months): $160,836.95
Insider Selling (Last 12 Months): $0.00

CymaBay Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at CymaBay Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CymaBay Therapeutics Share Price & Price History

Current Price: $3.42
Price Change: Price Increase of +0.02 (0.59%)
As of 09/26/2022 04:26 PM ET

This chart shows the closing price history over time for CBAY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

CymaBay Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/6/2022Sujal ShahCEOBuy51,301$1.95$100,036.95171,301View SEC Filing Icon  
1/19/2022Dennis D. KimInsiderBuy20,000$3.04$60,800.00View SEC Filing Icon  
10/10/2019Sujal ShahCEOBuy5,000$4.30$21,500.00120,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for CymaBay Therapeutics (NASDAQ:CBAY)

74.92% of CymaBay Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CBAY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

CymaBay Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/30/2022Verition Fund Management LLC15,800$47K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/22/2022ExodusPoint Capital Management LP13,535$40K0.0%-66.4%0.016%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.255,043$0.75M0.0%-54.8%0.301%Search for SEC Filing on Google Icon
8/16/2022Jane Street Group LLC12,252$36K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD122,200$0.36M0.0%+11.0%0.144%Search for SEC Filing on Google Icon
8/16/2022DAFNA Capital Management LLC1,787,569$5.27M1.4%+5.6%2.111%Search for SEC Filing on Google Icon
8/15/2022State Street Corp362,120$1.07M0.0%-73.3%0.428%Search for SEC Filing on Google Icon
8/15/2022Nantahala Capital Management LLC2,644,306$7.80M0.4%+39.6%3.123%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC51,334$0.15M0.0%+52.4%0.061%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.350,000$1.03M0.0%N/A0.413%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP1,575,269$4.65M0.1%N/A1.860%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC3,015,496$8.90M0.0%+27.1%3.561%Search for SEC Filing on Google Icon
8/15/2022Sio Capital Management LLC555,610$1.64M0.6%-1.2%0.656%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC514,620$1.52M0.0%+12.0%0.608%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp138,989$0.41M0.0%-81.0%0.164%Search for SEC Filing on Google Icon
8/12/2022Affinity Asset Advisors LLC1,372,244$4.05M1.7%+7.9%1.621%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC27,810$82K0.0%+15.7%0.033%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG455,265$1.34M0.0%+1,347.2%0.538%Search for SEC Filing on Google Icon
8/8/2022CM Management LLC210,000$0.62M0.7%+40.0%0.248%Search for SEC Filing on Google Icon
8/8/2022Y Intercept Hong Kong Ltd23,644$70K0.0%N/A0.028%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.145,913$0.43M0.0%+117.1%0.172%Search for SEC Filing on Google Icon
7/29/2022Myriad Asset Management US LP30,000$89K0.0%N/A0.035%Search for SEC Filing on Google Icon
7/20/2022Clear Harbor Asset Management LLC15,600$46K0.0%+47.2%0.018%Search for SEC Filing on Google Icon
7/14/2022LVM Capital Management Ltd. MI10,000$30K0.0%N/A0.012%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank8,381$26K0.0%N/A0.010%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE74,476$0.23M0.0%-13.9%0.088%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA9,996$31K0.0%-92.0%0.012%Search for SEC Filing on Google Icon
5/17/2022Prosight Management LP93,923$0.29M0.2%-43.7%0.111%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.564,116$1.75M0.0%+32.1%0.666%Search for SEC Filing on Google Icon
5/16/2022State Street Corp1,358,050$4.22M0.0%+1.8%1.604%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.222,495$0.69M0.0%-14.8%0.263%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG31,459$99K0.0%-44.9%0.037%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC459,535$1.43M0.0%+113.1%0.543%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp731,717$2.28M0.0%+20.7%0.864%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.239,215$0.74M0.0%+32.9%0.282%Search for SEC Filing on Google Icon
5/13/2022Nantahala Capital Management LLC1,893,997$5.89M0.3%-5.3%2.237%Search for SEC Filing on Google Icon
5/13/2022Affinity Asset Advisors LLC1,272,244$3.96M0.6%+13.4%1.502%Search for SEC Filing on Google Icon
5/13/2022XTX Topco Ltd17,183$53K0.0%N/A0.020%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.3,842,376$11.95M0.0%+1.4%4.538%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP940,806$2.93M0.0%+18.4%1.111%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.5,466,209$17M0.0%+2.7%6.455%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC52,338$0.16M0.0%N/A0.062%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.67,221$0.21M0.0%N/A0.079%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp276,766$0.86M0.0%+8.6%0.327%Search for SEC Filing on Google Icon
5/11/2022Raymond James & Associates97,604$0.30M0.0%+26.3%0.115%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.1,303,711$4.06M0.0%-5.7%1.540%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP192,244$0.60M0.1%-16.5%0.227%Search for SEC Filing on Google Icon
5/6/2022Great Lakes Advisors LLC10,105$31K0.0%N/A0.012%Search for SEC Filing on Google Icon
5/4/2022ClariVest Asset Management LLC133,000$0.41M0.0%-12.8%0.157%Search for SEC Filing on Google Icon
4/29/2022SG Americas Securities LLC10,900$34K0.0%-42.1%0.013%Search for SEC Filing on Google Icon
4/20/2022Pinnacle Wealth Planning Services Inc.29,223$91K0.0%N/A0.035%Search for SEC Filing on Google Icon
2/18/2022TCG Crossover Management LLC5,905,400$19.96M9.3%N/A8.554%Search for SEC Filing on Google Icon
2/15/2022Sender Co & Partners Inc.61,080$0.21M0.1%N/A0.088%Search for SEC Filing on Google Icon
2/15/2022Stonepine Capital Management LLC300,000$1.01M0.5%N/A0.435%Search for SEC Filing on Google Icon
2/15/2022Lynx1 Capital Management LP1,224,968$4.14M3.6%N/A1.774%Search for SEC Filing on Google Icon
2/15/2022Commodore Capital LP5,419,896$18.32M4.2%+30.0%7.850%Search for SEC Filing on Google Icon
2/15/2022683 Capital Management LLC1,100,000$3.72M0.1%N/A1.593%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC58,035$0.20M0.0%N/A0.084%Search for SEC Filing on Google Icon
2/14/2022Altium Capital Management LP1,750,000$5.92M1.6%N/A2.535%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.681,401$2.30M0.0%N/A0.987%Search for SEC Filing on Google Icon
2/14/2022DAFNA Capital Management LLC1,787,569$6.04M1.5%+241.0%2.589%Search for SEC Filing on Google Icon
2/14/2022ClariVest Asset Management LLC152,500$0.52M0.0%+34.4%0.221%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP230,258$0.78M0.1%-12.9%0.333%Search for SEC Filing on Google Icon
2/14/2022Rockefeller Capital Management L.P.226,850$0.77M0.0%+82.9%0.329%Search for SEC Filing on Google Icon
2/14/2022Affinity Asset Advisors LLC1,122,244$3.79M1.4%N/A1.625%Search for SEC Filing on Google Icon
2/10/2022Bailard Inc.13,700$46K0.0%N/A0.020%Search for SEC Filing on Google Icon
2/10/2022Massachusetts Financial Services Co. MA196,052$0.66M0.0%-17.5%0.284%Search for SEC Filing on Google Icon
2/9/2022BNP Paribas Arbitrage SA124,799$0.42M0.0%+798.9%0.181%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP794,841$2.69M0.0%+2.1%1.151%Search for SEC Filing on Google Icon
2/8/2022Raymond James & Associates77,267$0.26M0.0%-7.0%0.112%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC27,065$92K0.0%+14.6%0.039%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp606,077$2.05M0.0%-1.0%0.878%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC18,817$64K0.0%-59.2%0.027%Search for SEC Filing on Google Icon
2/3/2022Nisa Investment Advisors LLC10,470$31K0.0%+810.4%0.015%Search for SEC Filing on Google Icon
1/18/2022Miracle Mile Advisors LLC25,000$85K0.0%-50.0%0.036%Search for SEC Filing on Google Icon
12/29/2021Hudson Bay Capital Management LP380,052$1.39M0.0%+26.7%0.550%Search for SEC Filing on Google Icon
11/16/2021Opaleye Management Inc.115,015$0.42M0.1%N/A0.167%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC13,995$51K0.0%-67.5%0.020%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP383,738$1.40M0.0%-54.8%0.556%Search for SEC Filing on Google Icon
11/16/2021Metropolitan Life Insurance Co NY20,041$73K0.0%N/A0.029%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC1,958,653$7.15M0.0%-14.9%2.839%Search for SEC Filing on Google Icon
11/16/2021Commodore Capital LP4,169,896$15.22M4.0%+18.1%6.044%Search for SEC Filing on Google Icon
11/15/2021Golden State Equity Partners32,850$0.12M0.0%N/A0.048%Search for SEC Filing on Google Icon
11/15/2021Dimensional Fund Advisors LP778,115$2.84M0.0%-33.0%1.128%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.114,218$0.42M0.0%+419.1%0.166%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP264,224$0.96M0.1%+102.2%0.383%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC512,591$1.87M0.0%-35.6%0.743%Search for SEC Filing on Google Icon
11/12/2021Rockefeller Capital Management L.P.124,000$0.45M0.0%+25.3%0.180%Search for SEC Filing on Google Icon
11/12/2021The Manufacturers Life Insurance Company22,272$81K0.0%-47.9%0.032%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC1,107,091$4.04M0.0%-3.4%1.605%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.12,024$44K0.0%+54.2%0.017%Search for SEC Filing on Google Icon
11/10/2021Rafferty Asset Management LLC26,748$98K0.0%N/A0.039%Search for SEC Filing on Google Icon
11/10/2021Massachusetts Financial Services Co. MA237,773$0.87M0.0%-1.3%0.345%Search for SEC Filing on Google Icon
11/9/2021Barclays PLC28,332$0.10M0.0%+215.4%0.041%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.5,205,478$19M0.0%-4.2%7.544%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG167,066$0.61M0.0%-59.0%0.242%Search for SEC Filing on Google Icon
11/3/2021Dupont Capital Management Corp56,651$0.21M0.0%-12.4%0.082%Search for SEC Filing on Google Icon
11/2/2021Raymond James Financial Services Advisors Inc.11,091$40K0.0%-30.3%0.016%Search for SEC Filing on Google Icon
11/2/2021Raymond James & Associates83,058$0.30M0.0%-16.6%0.120%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund29,701$0.11M0.0%-46.0%0.043%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CymaBay Therapeutics logo
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California.
Read More on CymaBay Therapeutics

Today's Range

Now: $3.42
Low: $3.39
High: $3.54

50 Day Range

MA: $3.67
Low: $3.11
High: $4.25

52 Week Range

Now: $3.42
Low: $1.67
High: $4.74

Volume

38,154 shs

Average Volume

578,267 shs

Market Capitalization

$289.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62

Who are the company insiders with the largest holdings of CymaBay Therapeutics?

CymaBay Therapeutics' top insider shareholders include:
  1. Sujal Shah (CEO)
  2. Dennis D Kim (Insider)
Learn More about top insider investors at CymaBay Therapeutics.

Who are the major institutional investors of CymaBay Therapeutics?

CymaBay Therapeutics' top institutional investors include:
  1. Millennium Management LLC — 3.56%
  2. Nantahala Capital Management LLC — 3.12%
  3. DAFNA Capital Management LLC — 2.11%
  4. Laurion Capital Management LP — 1.86%
  5. Affinity Asset Advisors LLC — 1.62%
  6. Sio Capital Management LLC — 0.66%
Learn More about top institutional investors of CymaBay Therapeutics stock.

Which major investors are selling CymaBay Therapeutics stock?

In the previous quarter, CBAY stock was sold by these institutional investors:
  1. State Street Corp
  2. Northern Trust Corp
  3. Goldman Sachs Group Inc.
  4. ExodusPoint Capital Management LP
  5. Sio Capital Management LLC
  6. Citadel Advisors LLC
  7. Group One Trading L.P.

Which major investors are buying CymaBay Therapeutics stock?

During the previous quarter, CBAY stock was bought by institutional investors including:
  1. Laurion Capital Management LP
  2. Nantahala Capital Management LLC
  3. Millennium Management LLC
  4. UBS Group AG
  5. Point72 Asset Management L.P.
  6. Affinity Asset Advisors LLC
  7. DAFNA Capital Management LLC
  8. Connor Clark & Lunn Investment Management Ltd.
In the previous year, these company insiders have bought CymaBay Therapeutics stock:
  1. Sujal Shah (CEO)
  2. Dennis D Kim (Insider)
Learn More investors buying CymaBay Therapeutics stock.